Publication

Lipidated PrRP31 metabolites are long acting dual GPR10 and NPFF2 receptor agonists with potent body weight lowering effect

Scientific Reports 12:1696, 2022

Alexopoulou F, Bech EM, Pedersen SL, Thorbek DD, Leurs U, Rudkjær LCB, Fosgerau K, Hansen HH, Vrang N, Jelsing J, Elster L

Subjects
Therapeutic AreaDIO mouseTargetMouseCompoundMethod/EndpointSpeciesBody weightObesityDrug discoveryG-protein coupled receptor 10 (GPR10)Neuropeptide FF receptor type 2GUB08-248GUB08251Peptide chemistryPharmacokineticsReal-time food intake/activity analysisReceptor bindingProlactin-releasing peptideSemaglutide

Share this page

Resource Library

Related resources
Publication
Protection against overfeeding-induced weight gain is preserved in obesity but does not require FGF21 or MC4R
Publication
Whole-brain activation signatures of weight-lowering drugs
Publication
Glucagon resistance at the level of amino acid turnover in obese subjects with hepatic steatosis
Publication
Glucagon-like peptide-1 receptor agonists increase pancreatic mass by induction of protein synthesis

For further information

Contact us

Gubra

Hørsholm Kongevej 11B
2970 Hørsholm
Denmark

+45 3152 ­2650

Back To Top